Published in J Natl Cancer Inst on May 26, 2010
Quality control of natural product medicine and nutrient supplements 2014. J Anal Methods Chem (2014) 0.75
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial. J Natl Cancer Inst (2010) 1.59
Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat (2008) 1.86
Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat (2007) 1.32
Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment. BMC Med Genomics (2011) 1.17
Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol Cancer Ther (2010) 1.10
Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan. Bone (2012) 1.01
High performance plasmonic crystal sensor formed by soft nanoimprint lithography. Opt Express (2005) 0.96
Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy. Appl Health Econ Health Policy (2012) 0.95
Effectiveness of bed bug monitors for detecting and trapping bed bugs in apartments. J Econ Entomol (2011) 0.94
Pavlovian eyeblink conditioning in combat veterans with and without post-traumatic stress disorder. Integr Physiol Behav Sci (2004) 0.86
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease. Am J Gastroenterol (2007) 0.84
PC-SPES--a lesson for future dietary supplement research. J Natl Cancer Inst (2002) 0.81
Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured. Curr Med Res Opin (2014) 0.77
The response of a bone resorption marker to marine recruit training. Mil Med (2003) 0.75
The Coblentz William G. Fateley endowment. Appl Spectrosc (2011) 0.75